Jonathan Berman

Jonathan Berman has over 20 years of litigation experience, focusing on antitrust cases, class actions, and other complex litigation matters. He focuses on the interplay between civil litigation and the laws administered by the Food and Drug Administration. Jonathan also has advised clients, on dozens of matters, regarding FDA law and practice.

Jonathan's antitrust docket has included cases involving allegations of product-hopping, pay-for-delay, and price-fixing, government challenges to mergers, exclusive contracts, and a variety of rule-of-reason and monopolization theories. He frequently litigates on behalf of clients in the health care sector. Jonathan has represented, in major litigation, pharmaceutical companies, a drug wholesaler, an insurer, and hospitals. [1]